BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 2348208)

  • 1. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer.
    Gwinn ML; Lee NC; Rhodes PH; Layde PM; Rubin GL
    J Clin Epidemiol; 1990; 43(6):559-68. PubMed ID: 2348208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for ovarian cancer: a case-control study.
    Booth M; Beral V; Smith P
    Br J Cancer; 1989 Oct; 60(4):592-8. PubMed ID: 2679848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer before age 45 and oral contraceptive use: new findings.
    Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
    Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.
    Jorgensen C; Picot MC; Bologna C; Sany J
    Ann Rheum Dis; 1996 Feb; 55(2):94-8. PubMed ID: 8712873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and breast cancer risk among younger women.
    Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
    J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk.
    Harlow BL; Cramer DW; Geller J; Willett WC; Bell DA; Welch WR
    Am J Epidemiol; 1991 Sep; 134(5):445-53. PubMed ID: 1897499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for epithelial ovarian cancer in Beijing, China.
    Chen Y; Wu PC; Lang JH; Ge WJ; Hartge P; Brinton LA
    Int J Epidemiol; 1992 Feb; 21(1):23-9. PubMed ID: 1544753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54.
    Mayberry RM
    Ann Epidemiol; 1994 May; 4(3):205-13. PubMed ID: 8055121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and neoplasia of the ovary.
    Stanford JL
    Contraception; 1991 Jun; 43(6):543-56. PubMed ID: 1868732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk in relation to type of estrogen contained in oral contraceptives.
    Schlesselman JJ; Stadel BV; Murray P; Lai SH
    Contraception; 1987 Dec; 36(6):595-613. PubMed ID: 3446437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and premenopausal breast cancer in nulliparous women.
    Stadel BV; Lai SH; Schlesselman JJ; Murray P
    Contraception; 1988 Sep; 38(3):287-99. PubMed ID: 3168449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.